Vanda Pharmaceuticals Inc (VNDA)
4.94
+0.04
(+0.82%)
USD |
NASDAQ |
Nov 21, 16:00
4.935
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals 1 Year Total Returns (Daily): 43.19% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | 43.19% |
November 20, 2024 | 36.87% |
November 19, 2024 | 38.59% |
November 18, 2024 | 40.28% |
November 15, 2024 | 40.85% |
November 14, 2024 | 43.66% |
November 13, 2024 | 60.12% |
November 12, 2024 | 58.36% |
November 11, 2024 | 56.60% |
November 08, 2024 | 19.86% |
November 07, 2024 | 13.32% |
November 06, 2024 | 9.64% |
November 05, 2024 | 5.97% |
November 04, 2024 | 7.30% |
November 01, 2024 | 6.64% |
October 31, 2024 | 6.16% |
October 30, 2024 | 5.07% |
October 29, 2024 | 13.01% |
October 28, 2024 | 15.18% |
October 25, 2024 | 6.31% |
October 24, 2024 | 7.11% |
October 23, 2024 | 10.61% |
October 22, 2024 | 8.99% |
October 21, 2024 | 8.99% |
October 18, 2024 | 9.60% |
Date | Value |
---|---|
October 17, 2024 | 5.46% |
October 16, 2024 | 11.11% |
October 15, 2024 | 12.94% |
October 14, 2024 | 13.18% |
October 11, 2024 | -1.77% |
October 10, 2024 | -2.86% |
October 09, 2024 | -0.45% |
October 08, 2024 | -1.97% |
October 07, 2024 | -1.75% |
October 04, 2024 | 7.67% |
October 03, 2024 | 8.96% |
October 02, 2024 | 10.07% |
October 01, 2024 | 5.09% |
September 30, 2024 | 8.56% |
September 27, 2024 | 0.43% |
September 26, 2024 | 4.41% |
September 25, 2024 | 8.99% |
September 24, 2024 | 9.98% |
September 23, 2024 | 5.32% |
September 20, 2024 | 7.71% |
September 19, 2024 | 5.92% |
September 18, 2024 | 10.99% |
September 17, 2024 | 5.11% |
September 16, 2024 | 8.09% |
September 13, 2024 | 7.37% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.48%
Minimum
Nov 10 2023
127.2%
Maximum
Mar 18 2021
-15.30%
Average
-29.83%
Median
1 Year Total Returns (Daily) Benchmarks
Zevra Therapeutics Inc | 102.4% |
Black Diamond Therapeutics Inc | 8.97% |
Edgewise Therapeutics Inc | 404.4% |
NovaBay Pharmaceuticals Inc | -93.43% |
Palatin Technologies Inc | -53.31% |